Huang X, Xu R, Yang Q, Jiang X, Lin J, Zhao H
Front Cell Infect Microbiol. 2024; 14:1505958.
PMID: 39664494
PMC: 11632464.
DOI: 10.3389/fcimb.2024.1505958.
Moragas N, Fernandez-Nogueira P, Recalde-Percaz L, Inman J, Lopez-Plana A, Bergholtz H
Breast Cancer Res. 2024; 26(1):122.
PMID: 39138514
PMC: 11320849.
DOI: 10.1186/s13058-024-01871-0.
Barbosa L, Machado G, Heringer M, Ferrer V
Neurogenetics. 2024; 25(3):249-262.
PMID: 38775886
DOI: 10.1007/s10048-024-00763-x.
Song H, Jiang H, Hu W, Hai Y, Cai Y, Li H
Sci Adv. 2024; 10(20):eadl3511.
PMID: 38748808
PMC: 11095500.
DOI: 10.1126/sciadv.adl3511.
Jacksi M, Schad E, Tantos A
Biomolecules. 2024; 14(4).
PMID: 38672463
PMC: 11047920.
DOI: 10.3390/biom14040445.
Noncoding SNP at rs1663689 represses ADGRG6 via interchromosomal interaction and reduces lung cancer progression.
Lei X, Tian X, Wang H, Xu X, Li G, Liu W
EMBO Rep. 2023; 24(7):e56212.
PMID: 37154297
PMC: 10328068.
DOI: 10.15252/embr.202256212.
EPRS1 correlates with malignant progression in hepatocellular carcinoma.
Yang C, Yang X, Liu C, Hou J, Chen X, Wang L
Infect Agent Cancer. 2023; 18(1):27.
PMID: 37138286
PMC: 10155449.
DOI: 10.1186/s13027-023-00503-0.
Expression of laminin-1 and matrix metalloproteinase-9 in benign and malignant endometrium.
Kucukaydin Z, Basaran M, Unlu Y, Basaran A, Kurdoglu M
Turk J Med Sci. 2023; 53(1):149-159.
PMID: 36945954
PMC: 10388054.
DOI: 10.55730/1300-0144.5568.
Association of LAMA1 Single-Nucleotide Polymorphisms with Risk of Esophageal Squamous Cell Carcinoma among the Eastern Chinese Population.
Zhang S, Fang Y, Su F, Jiang T, Yu J, Lin S
J Oncol. 2023; 2023:6922909.
PMID: 36824663
PMC: 9943613.
DOI: 10.1155/2023/6922909.
A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Xu R, Wang F, Sun J, Abuduwaili W, Zhang G, Liu Z
J Transl Med. 2022; 20(1):579.
PMID: 36494846
PMC: 9733131.
DOI: 10.1186/s12967-022-03791-z.
Cancer Progression Mediated by CAFs Relating to HCC and Identification of Genetic Characteristics Influencing Prognosis.
Song L, Li Q, Lu Y, Feng X, Yang R, Wang S
J Oncol. 2022; 2022:2495361.
PMID: 36299502
PMC: 9590114.
DOI: 10.1155/2022/2495361.
Anti-Laminin 332-Type Mucous Membrane Pemphigoid.
Shi L, Li X, Qian H
Biomolecules. 2022; 12(10).
PMID: 36291670
PMC: 9599625.
DOI: 10.3390/biom12101461.
Mural Wnt/β-catenin signaling regulates Lama2 expression to promote neurovascular unit maturation.
Biswas S, Shahriar S, Giangreco N, Arvanitis P, Winkler M, Tatonetti N
Development. 2022; 149(17).
PMID: 36098369
PMC: 9578690.
DOI: 10.1242/dev.200610.
N-glycoproteomic profiling revealing novel coronavirus therapeutic targets potentially involved in Cepharanthine's intervention.
An W, Tian F, Li J, Chen J, Tong Y
Med Nov Technol Devices. 2022; 16:100156.
PMID: 35879945
PMC: 9301903.
DOI: 10.1016/j.medntd.2022.100156.
LINC00922 promotes deterioration of gastric cancer.
Ge H, Yan Y, Tian F, Guo L, He X, Wang C
PLoS One. 2022; 17(5):e0267798.
PMID: 35511773
PMC: 9070913.
DOI: 10.1371/journal.pone.0267798.
The Endoplasmic Reticulum-Stressed Head and Neck Squamous Cell Carcinoma Cells Induced Exosomal miR-424-5p Inhibits Angiogenesis and Migration of Humanumbilical Vein Endothelial Cells Through LAMC1-Mediated Wnt/β-Catenin Signaling Pathway.
Wang Z, Jiao P, Zhong Y, Ji H, Zhang Y, Song H
Cell Transplant. 2022; 31:9636897221083549.
PMID: 35315295
PMC: 8943634.
DOI: 10.1177/09636897221083549.
Laminin N-terminus α31 is upregulated in invasive ductal breast cancer and changes the mode of tumour invasion.
Troughton L, OLoughlin D, Zech T, Hamill K
PLoS One. 2022; 17(3):e0264430.
PMID: 35231053
PMC: 8887744.
DOI: 10.1371/journal.pone.0264430.
Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma.
Tessiri S, Techasen A, Kongpetch S, Namjan A, Loilome W, Chan-On W
PeerJ. 2022; 10:e12750.
PMID: 35070505
PMC: 8761367.
DOI: 10.7717/peerj.12750.
Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer.
Zhang Z, Liang Z, Li D, Wang L, Chen Y, Liang Y
Hum Cell. 2022; 35(2):649-664.
PMID: 35044630
DOI: 10.1007/s13577-022-00673-w.
Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic.
Ljubimov V, Ramesh A, Davani S, Danielpour M, Breunig J, Black K
Adv Drug Deliv Rev. 2021; 181:114033.
PMID: 34808227
PMC: 8604570.
DOI: 10.1016/j.addr.2021.114033.